Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
cancer drugs
3
×
clinical trials
ipo
3
×
life sciences
national blog main
sanofi
investing
national top stories
revolution medicines
san francisco
san francisco blog main
san francisco top stories
the column group
third rock ventures
warp drive bio
agios pharmaceuticals
amgen
cobimetinib
colorectal cancer
david e. shaw
deals
drug discovery
enasidenib
fda
ivosidenib
mark goldsmith
materials science
morphic
new york
new york blog main
new york top stories
nimbus therapeutics
non-small cell lung cancer
pancreatic cancer
ras
roche
What
ipo
medicines
3
×
cancer
proteins
research
revolution
cancer’s
company’s
course
despite
development
discover
disease
drug
experimental
family
frontiers
growing
handiwork
hardest
helped
hit
hottest
hunters
internal
known
landscape
maps
parlance
pharmaceutical
pipeline
play
ras
reach
reels
revealed
role
scan
schrödinger
schrödinger’s
Language
unset
Current search:
medicines
×
ipo
×
" cancer drugs "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline